{{Drugbox
| IUPAC_name = 1-(oxan-4-ylmethyl)-N-(2-phenylpropan-2-yl)indazole-3-carboxamide
| image = CUMYL-THPINACA.png

<!--Clinical data-->
| tradename =  
| pregnancy_AU = 
| pregnancy_US = 
| pregnancy_category =  
| legal_AU = 
| legal_CA = Schedule II
| legal_UK = 
| legal_US = 
| legal_status = Illegal in China and Sweden
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = 
| CAS_number = 1400742-50-8
| ATC_prefix =  
| ATC_suffix =  
| PubChem =  86273679
| ChemSpiderID = 48057932
| smiles            = O=C(NC(C)(C)C1=CC=CC=C1)C2=NN(CC3CCOCC3)C4=C2C=CC=C4
| StdInChI          = 1S/C23H27N3O2/c1-23(2,18-8-4-3-5-9-18)24-22(27)21-19-10-6-7-11-20(19)26(25-21)16-17-12-14-28-15-13-17/h3-11,17H,12-16H2,1-2H3,(H,24,27)
| StdInChIKey       = HINCNLQQLQFMRD-UHFFFAOYSA-N


<!--Chemical data-->
| C=23 | H=27 | N=3 | O=2
| molecular_weight = 377.5 g/mol
}}

'''CUMYL-THPINACA''' (also known as '''SGT-42''') is an [[indazole]]-3-carboxamide based [[synthetic cannabinoid]].<ref>{{cite web | url=https://www.caymanchem.com/app/template/Product.vm/catalog/17210 | title=CUMYL-THPINACA | publisher=Cayman Chemical | accessdate=11 July 2015}}</ref> CUMYL-THPINACA acts as a potent [[agonist]] for the [[cannabinoid receptor]]s, with approximately 6x selectivity for [[CB1 receptor|CB<sub>1</sub>]], having an EC<sub>50</sub> of 0.1nM for human [[CB1 receptor|CB<sub>1</sub> receptors]] and 0.59nM for human [[CB2 receptor|CB<sub>2</sub> receptors]].<ref>{{cite web | url=https://www.google.com/patents/WO2014167530A1 | title=Patent WO 2014167530 - Cannabinoid compounds | work=New Zealand Patent application 623626 | date=11 April 2013 | accessdate=11 July 2015 | author=Bowden|display-authors=etal}}</ref>

== Legal status ==

Sweden's public health agency suggested to classify CUMYL-THPINACA as hazardous substance on November 10, 2014.<ref>{{cite web | url=http://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2014/november/cannabinoider-foreslas-bli-klassade-som-halsofarlig-vara/ | title=Cannabinoider föreslås bli klassade som hälsofarlig vara  | accessdate=11 July 2015}}</ref>

As of October 2015 CUMYL-THPINACA is a controlled substance in China.<ref>{{cite web | url=http://www.sfda.gov.cn/WS01/CL0056/130753.html | title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知 | publisher=China Food and Drug Administration | date=27 September 2015 | language=Chinese | accessdate=1 October 2015}}</ref>

==See also==
* [[5F-CUMYL-PINACA]]
* [[5F-SDB-006]]
* [[ADAMANTYL-THPINACA]]
* [[CUMYL-PICA]]
* [[CUMYL-PINACA]]
* [[SDB-006]]
* [[NNE1]]

==References==
{{Reflist}}

{{Cannabinoids}}
{{Cannabinoidergics}}

[[Category:Cannabinoids]]
[[Category:Designer drugs]]
[[Category:Indazolecarboxamides]]

{{cannabinoid-stub}}